Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases—an overview. Curr Pharm Des 2008;14:603–614.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008;14:641–648.
   PubMed Web of Science ®Google Scholar
• Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995;64:375–401.
   PubMed Web of Science ®Google Scholar
• Ozensoy O, Arslan O, Sinan SO. A new method for purification of carbonic anhydrase isozymes by affinity chromatography. Biochemistry Mosc 2004;69:216–219.
   PubMed Web of Science ®Google Scholar
• Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:9101–9105.
   PubMed Web of Science ®Google Scholar
• Sentürk M, Talaz O, Ekinci D, Cavdar H, Küfrevioglu OI. In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates. Bioorg Med Chem Lett 2009;19:3661–3663.
   PubMed Web of Science ®Google Scholar
• Parkkila S, Parkkila AK. Carbonic anhydrase in the alimentary tract. Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal. Scand J Gastroenterol 1996;31:305–317.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199–229.
   PubMed Web of Science ®Google Scholar
• Nair SK, Ludwig PA, Christianson DW. Two-site binding of phenol in the active site of human carbonic anhydrase II: structural implications for substrate association. J Am Chem Soc 1994;116:3659–3660.
   Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008;18:1583–1587.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, Supuran CT. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives Bioorg Med Chem 2008;16:7424–7428.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Hilvo M, Scozzafava A, Parkkila S, Supuran CT. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 2008;18:3593–3596.
   PubMed Web of Science ®Google Scholar
• Coban TA, Beydemir S, Gulcin I, Ekinci D. The inhibitory effect of ethanol on Carbonic Anhydrase isoenzymes: An in vivo and in vitro study J Enzyme Inhib Med Chem 2008; 23:266–270.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Ceyhun SB, Sentürk M, Erdem D, Küfrevioglu OI, Supuran CT. Characterization and anions inhibition studies of an a-carbonic anhydrase from the teleost fish Dicentrarchus labrax. Bioorg Med Chem 2011;19:744–748.
   PubMed Web of Science ®Google Scholar
• Hilvo M, Tolvanen M, Clark A, Shen B, Shah GN, Waheed A et al. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 2005;392:83–92.
   PubMed Web of Science ®Google Scholar
• Hilvo M, Baranauskiene L, Salzano AM, Scaloni A, Matulis D, Innocenti A et al. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 2008;283:27799–27809.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Beydemir S, Küfrevioglu OI. In vitro inhibitory effects of some heavy metals on human erythrocyte carbonic anhydrases. J Enzyme Inhib Med Chem 2007;22:745–750.
   PubMed Web of Science ®Google Scholar
• Haadsma-Svensson SR, Svensson KA. PNU-99194A: a preferential dopamine D3 receptor antagonist. CNS Drug Rev 1998;4:42–57.
   Google Scholar
• Cannon JG. Dopamine agonists: structure-activity relationships. Prog Drug Res 1985;29:303–414.
   PubMedGoogle Scholar
• Gray AP, Reit E, Ackerly JA. Conformational requirements for direct adrenergic stimulation. J Med Chem 1973;16:1023–1027.
   PubMed Web of Science ®Google Scholar
• Jagoe CT, Kreifels SE, Li J. Covalent binding of catechols to src family SH2 domains. Bioorg Med Chem Lett 1997;7:113–116.
   Web of Science ®Google Scholar
• Richter H, Schenck M, German Patent 952441 1956; Chem. Abstr., 1959, 53, 2190e.
   Google Scholar
• Haadsma-Svensson SR, Cleek KA, Dinh DM, Duncan JN, Haber CL, Huff RM et al. Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans. J Med Chem 2001;44:4716–4732.
   PubMed Web of Science ®Google Scholar
• Kivelä J, Parkkila S, Waheed A, Parkkila AK, Sly WS, Rajaniemi H. Secretory carbonic anhydrase isoenzyme (CA VI) in human serum. Clin Chem 1997;43:2318–2322.
   PubMed Web of Science ®Google Scholar
• Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–4229.
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissocation constants. J Am Chem Soc 1934;56:658–666.
   Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Laemmli DK. Cleavage of structural proteins during in assembly of the head of Bacteriophage T4. Nature 1970;227:680–685.
   PubMed Web of Science ®Google Scholar
• Vomasta D, Innocenti A, König B, Supuran CT. Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivatives. Bioorg Med Chem Lett 2009;19:1283–1286.
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, Scozzafava A, Kaila K, Supuran CT. Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines. Bioorg Med Chem Lett 2007;17:4107–4112.
   PubMed Web of Science ®Google Scholar
• Ilies M, Scozzafava A, Supuran CT. Carbonic anhydrase activators. In Carbonic anhydrase – Its inhibitors and activators; Supuran CT, Scozzafava A, Conway J, Eds.; CRC Press: Boca Raton (FL), USA, 2004; p 317.
   Google Scholar
• Innocenti A, Maresca A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors? Bioorg Med Chem Lett 2008;18:3938–3941.
   PubMed Web of Science ®Google Scholar
• Hisar O, Beydemir S, Gülçin I, Küfrevioglu OI, Supuran CT. Effects of low molecular weight plasma inhibitors of rainbow trout (Oncorhynchus mykiss) on human erythrocyte carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2005;20:35–39.
   PubMed Web of Science ®Google Scholar
• Abdülkadir Coban T, Beydemir S, Gülcin I, Gücin I, Ekinci D, Innocenti A et al. Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. Bioorg Med Chem 2009;17:5791–5795.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Beydemir S, Alim Z. Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacol Rep 2007;59:580–587.
   PubMed Web of Science ®Google Scholar